Last reviewed · How we verify
XYLITOL
At a glance
| Generic name | XYLITOL |
|---|---|
| Drug class | Non-Standardized Food Allergenic Extract [EPC] |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
- Prevention of dental caries
Common side effects
Key clinical trials
- Consumption of Oral Artificial Sweeteners on Platelet Aggregation and Polyol Excretion (NA)
- Efficacy and Safety of XyloCore Peritoneal Dialysis Solution. (PHASE3)
- The Effect of Chewing Gum on Nausea, Vomiting and Bowel Function After Colorectal Surgery (NA)
- Microbiome Alterations With Xylitol (MAX) in Pregnancy (PHASE1,PHASE2)
- Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia (PHASE3)
- Laser Therapy for Dentin Hypersensitivity (NA)
- Xylitol Use for Decolonization of C. Difficile in Patients With IBD (PHASE1)
- Xylitol and the Prevention of Periodontal Disease and Preterm Birth Trial (PHASE2,PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- XYLITOL CI brief — competitive landscape report
- XYLITOL updates RSS · CI watch RSS